James Robinson (biopharmacist)

James Robinson
James Robinson
	Scientific career
Institutions	G.D. Searle, LLC ; Sanofi Pasteur ; Novavax ; Merck ; Coalition for Epidemic Preparedness Innovations (CEPI)

James (Jim) Robinson is the vice chair of the Coalition for Epidemic Preparedness Innovations (CEPI).

Robinson manages the CEPI manufacturing strategy for a COVID-19 vaccine.[1]

Career

Robinson began his career as a biochemical engineer with G.D. Searle and worked at various companies before becoming the head of technical support for Merck's vaccine, biologics and sterile manufacturing in 2010.[2][3]

In 2017, Robinson began serving on CEPI's scientific advisory board. He was made vice-chair in 2019.[3]

References

Heath, Elizabeth Weise and David (26 April 2020). "'Our moon shot': The world needs a coronavirus vaccine ASAP. Despite drugmakers billion-dollar bets, one might not be available for years". USA TODAY. Retrieved 2020-05-20.
Dumiak, Michael (2017). "A Crisis Gives You WIngs". IAVI Report. Retrieved 2020-05-20.
Wright, Rob (27 March 2020). "The Little-Known Coalition Tasked With Saving The World From COVID-19". Life Science Leader. Retrieved 2020-05-20.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] Heath, Elizabeth Weise and David (26 April 2020). "'Our moon shot': The world needs a coronavirus vaccine ASAP. Despite drugmakers billion-dollar bets, one might not be available for years". USA TODAY. Retrieved 2020-05-20.

[2] Dumiak, Michael (2017). "A Crisis Gives You WIngs". IAVI Report. Retrieved 2020-05-20.

[:0-3] Wright, Rob (27 March 2020). "The Little-Known Coalition Tasked With Saving The World From COVID-19". Life Science Leader. Retrieved 2020-05-20.